Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

generic medicines

  1. Home>
  2. News>
  3. generic medicines>
  4. Page 14

Indian Pharma’s $250B 2030 Dream Threatened by Tariffs, Regulation

  • Post published:August 23, 2026
  • Post category:News

India's pharmaceutical industry has set its sights on a $250 billion export target by 2030 — but according to Reuters, the sector is on track to miss that goal, squeezed…

Continue Reading Indian Pharma’s $250B 2030 Dream Threatened by Tariffs, Regulation

Understanding CDSCO’s Generic Drug Approval Process in India: A 2026 Buyer’s Guide

  • Post published:August 22, 2026
  • Post category:Knowledge

India is the world's largest producer of generic medicines by volume, supplying over 20% of the global generic drug market. For buyers — whether hospitals, clinics, pharmacies, or individual patients…

Continue Reading Understanding CDSCO’s Generic Drug Approval Process in India: A 2026 Buyer’s Guide

CDSCO Staffing Gap Threatens India’s Pharma Export Ambitions

  • Post published:August 21, 2026
  • Post category:News

India wants to be the "pharmacy of the world" — a $250 billion pharmaceutical export powerhouse supplying affordable generics to every corner of the globe. But a single structural problem…

Continue Reading CDSCO Staffing Gap Threatens India’s Pharma Export Ambitions

How Indian Generic Medicine Quality Is Monitored in 2026

  • Post published:August 20, 2026
  • Post category:Knowledge

Indian generic medicines account for a substantial share of global pharmaceutical supply — the US alone sources an estimated 40% of its generic prescription drug volume from India. With this…

Continue Reading How Indian Generic Medicine Quality Is Monitored in 2026
  • Go to the previous page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 31
  • Go to the next page

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
    November 14, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide
  • India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve